vs
Portillo's Inc.（PTLO）与Ultragenyx Pharmaceutical Inc.（RARE）财务数据对比。点击上方公司名可切换其他公司
Ultragenyx Pharmaceutical Inc.的季度营收约是Portillo's Inc.的1.1倍（$207.3M vs $185.7M），Portillo's Inc.净利率更高（3.4% vs -62.0%，领先65.4%），Ultragenyx Pharmaceutical Inc.同比增速更快（25.9% vs 0.6%），Portillo's Inc.自由现金流更多（$-9.2M vs $-100.8M），过去两年Ultragenyx Pharmaceutical Inc.的营收复合增速更高（38.0% vs 5.8%）
Portillo's Inc.是总部位于美国芝加哥地区的休闲快餐连锁品牌，主打芝加哥风味美食，代表菜品包括芝加哥热狗、麦克斯韦街波兰香肠以及意式牛肉三明治。该品牌由迪克·波蒂略于1963年4月9日在伊利诺伊州维拉公园创立，最初门店名为“The Dog House”。
Ultragenyx Pharmaceutical Inc.是一家总部位于美国的生物制药企业，专注于研发罕见病和超罕见遗传病的创新治疗方案，这类疾病目前大多无获批疗法，存在大量未被满足的临床需求。公司覆盖生物制剂、小分子药物、基因疗法、反义寡核苷酸及mRNA等多种药物技术平台，研发管线涵盖骨骼、内分泌、代谢、肌肉及中枢神经系统疾病领域。
PTLO vs RARE — 直观对比
损益表 — Q4 FY2025 vs Q4 FY2025
| 指标 | | |
|---|---|---|
| 营收 | $185.7M | $207.3M |
| 净利润 | $6.3M | $-128.6M |
| 毛利率 | — | — |
| 营业利润率 | 5.6% | -54.7% |
| 净利率 | 3.4% | -62.0% |
| 营收同比 | 0.6% | 25.9% |
| 净利润同比 | -49.5% | 3.5% |
| 每股收益（稀释后） | $0.08 | $-1.28 |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比，按日历期对齐，财年错位的公司也能正确匹配
| Q4 25 | $185.7M | $207.3M | ||
| Q3 25 | $181.4M | $159.9M | ||
| Q2 25 | $188.5M | $166.5M | ||
| Q1 25 | $176.4M | $139.3M | ||
| Q4 24 | $184.6M | $164.6M | ||
| Q3 24 | $178.3M | $139.5M | ||
| Q2 24 | $181.9M | $147.0M | ||
| Q1 24 | $165.8M | $108.8M |
| Q4 25 | $6.3M | $-128.6M | ||
| Q3 25 | $1.2M | $-180.4M | ||
| Q2 25 | $8.7M | $-115.0M | ||
| Q1 25 | $3.3M | $-151.1M | ||
| Q4 24 | $12.4M | $-133.2M | ||
| Q3 24 | $7.2M | $-133.5M | ||
| Q2 24 | $6.5M | $-131.6M | ||
| Q1 24 | $4.6M | $-170.7M |
| Q4 25 | 5.6% | -54.7% | ||
| Q3 25 | 3.0% | -106.9% | ||
| Q2 25 | 9.3% | -64.8% | ||
| Q1 25 | 5.9% | -102.6% | ||
| Q4 24 | 7.5% | -74.3% | ||
| Q3 24 | 9.0% | -94.6% | ||
| Q2 24 | 10.0% | -79.1% | ||
| Q1 24 | 6.1% | -151.9% |
| Q4 25 | 3.4% | -62.0% | ||
| Q3 25 | 0.7% | -112.8% | ||
| Q2 25 | 4.6% | -69.0% | ||
| Q1 25 | 1.9% | -108.5% | ||
| Q4 24 | 6.7% | -80.9% | ||
| Q3 24 | 4.1% | -95.7% | ||
| Q2 24 | 3.6% | -89.5% | ||
| Q1 24 | 2.8% | -156.8% |
| Q4 25 | $0.08 | $-1.28 | ||
| Q3 25 | $0.02 | $-1.81 | ||
| Q2 25 | $0.12 | $-1.17 | ||
| Q1 25 | $0.05 | $-1.57 | ||
| Q4 24 | $0.17 | $-1.34 | ||
| Q3 24 | $0.11 | $-1.40 | ||
| Q2 24 | $0.10 | $-1.52 | ||
| Q1 24 | $0.08 | $-2.03 |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | | |
|---|---|---|
| 现金及短期投资手头流动性 | — | $421.0M |
| 总债务越低越好 | $334.2M | — |
| 股东权益账面价值 | $467.8M | $-80.0M |
| 总资产 | $1.6B | $1.5B |
| 负债/权益比越低杠杆越低 | 0.71× | — |
8季度趋势，按日历期对齐
| Q4 25 | — | $421.0M | ||
| Q3 25 | — | $202.5M | ||
| Q2 25 | — | $176.3M | ||
| Q1 25 | — | $127.1M | ||
| Q4 24 | — | $174.0M | ||
| Q3 24 | — | $150.6M | ||
| Q2 24 | — | $480.7M | ||
| Q1 24 | — | $112.3M |
| Q4 25 | $334.2M | — | ||
| Q3 25 | $322.6M | — | ||
| Q2 25 | $317.0M | — | ||
| Q1 25 | $319.8M | — | ||
| Q4 24 | $311.7M | — | ||
| Q3 24 | $302.2M | — | ||
| Q2 24 | $305.1M | — | ||
| Q1 24 | $321.7M | — |
| Q4 25 | $467.8M | $-80.0M | ||
| Q3 25 | $459.4M | $9.2M | ||
| Q2 25 | $458.9M | $151.3M | ||
| Q1 25 | $406.9M | $144.2M | ||
| Q4 24 | $401.1M | $255.0M | ||
| Q3 24 | $382.4M | $346.8M | ||
| Q2 24 | $370.2M | $432.4M | ||
| Q1 24 | $360.5M | $140.3M |
| Q4 25 | $1.6B | $1.5B | ||
| Q3 25 | $1.6B | $1.2B | ||
| Q2 25 | $1.6B | $1.3B | ||
| Q1 25 | $1.5B | $1.3B | ||
| Q4 24 | $1.5B | $1.5B | ||
| Q3 24 | $1.5B | $1.5B | ||
| Q2 24 | $1.4B | $1.6B | ||
| Q1 24 | $1.4B | $1.3B |
| Q4 25 | 0.71× | — | ||
| Q3 25 | 0.70× | — | ||
| Q2 25 | 0.69× | — | ||
| Q1 25 | 0.79× | — | ||
| Q4 24 | 0.78× | — | ||
| Q3 24 | 0.79× | — | ||
| Q2 24 | 0.82× | — | ||
| Q1 24 | 0.89× | — |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | | |
|---|---|---|
| 经营现金流最新季度 | $23.2M | $-99.8M |
| 自由现金流经营现金流 - 资本支出 | $-9.2M | $-100.8M |
| 自由现金流率自由现金流/营收 | -4.9% | -48.6% |
| 资本支出强度资本支出/营收 | 17.4% | 0.5% |
| 现金转化率经营现金流/净利润 | 3.69× | — |
| 过去12个月自由现金流最近4个季度 | $-18.5M | $-472.0M |
8季度趋势，按日历期对齐
| Q4 25 | $23.2M | $-99.8M | ||
| Q3 25 | $20.0M | $-91.4M | ||
| Q2 25 | $19.2M | $-108.3M | ||
| Q1 25 | $9.4M | $-166.5M | ||
| Q4 24 | $26.1M | $-79.3M | ||
| Q3 24 | $30.3M | $-67.0M | ||
| Q2 24 | $32.6M | $-77.0M | ||
| Q1 24 | $9.1M | $-190.7M |
| Q4 25 | $-9.2M | $-100.8M | ||
| Q3 25 | $-5.0M | $-92.7M | ||
| Q2 25 | $5.2M | $-110.7M | ||
| Q1 25 | $-9.6M | $-167.8M | ||
| Q4 24 | $-5.6M | $-79.5M | ||
| Q3 24 | $7.7M | $-68.6M | ||
| Q2 24 | $15.6M | $-79.0M | ||
| Q1 24 | $-7.9M | $-193.9M |
| Q4 25 | -4.9% | -48.6% | ||
| Q3 25 | -2.7% | -58.0% | ||
| Q2 25 | 2.8% | -66.5% | ||
| Q1 25 | -5.4% | -120.5% | ||
| Q4 24 | -3.0% | -48.3% | ||
| Q3 24 | 4.3% | -49.2% | ||
| Q2 24 | 8.6% | -53.7% | ||
| Q1 24 | -4.7% | -178.2% |
| Q4 25 | 17.4% | 0.5% | ||
| Q3 25 | 13.8% | 0.8% | ||
| Q2 25 | 7.5% | 1.5% | ||
| Q1 25 | 10.8% | 1.0% | ||
| Q4 24 | 17.2% | 0.1% | ||
| Q3 24 | 12.7% | 1.2% | ||
| Q2 24 | 9.3% | 1.4% | ||
| Q1 24 | 10.2% | 3.0% |
| Q4 25 | 3.69× | — | ||
| Q3 25 | 16.51× | — | ||
| Q2 25 | 2.21× | — | ||
| Q1 25 | 2.85× | — | ||
| Q4 24 | 2.10× | — | ||
| Q3 24 | 4.20× | — | ||
| Q2 24 | 5.03× | — | ||
| Q1 24 | 1.99× | — |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
业务分部营收拆解
PTLO
暂无分部数据
RARE
| Royalty | $105.6M | 51% |
| Products | $101.7M | 49% |
